| Literature DB >> 36002809 |
Yixiao Song1, Liping Wang1, Mingjie Zhang1, Xi Chen1, Yachang Pang1, Jiaqi Liu1, Zhuoming Xu2.
Abstract
BACKGROUND: Prolonged recovery is a severe issue in patients after Fontan operation. However, predictive factors related to this issue are not adequately evaluated. The present study aimed to investigate potential predictive factors which can predict Fontan postoperative recovery.Entities:
Keywords: Children; Fontan; Postoperative; Prolonged recovery
Mesh:
Year: 2022 PMID: 36002809 PMCID: PMC9404579 DOI: 10.1186/s12887-022-03537-2
Source DB: PubMed Journal: BMC Pediatr ISSN: 1471-2431 Impact factor: 2.567
Baseline preoperative data of the two groups
| Prolonged recovery | Standard recovery | ||
|---|---|---|---|
| ICU stay (day), median (IQR) | 7 (6–8) | 3 (3–4) | < 0.001* |
| Demographic data | |||
| Sex (male), n (%) | 39 (55.7) | 126 (59.4) | 0.584 |
| Age (year), mean ± SD | 4.17 ± 1.789 | 4.43 ± 1.988 | 0.317 |
| Height (cm), mean ± SD | 100.61 ± 12.957 | 102.04 ± 12.916 | 0.423 |
| Weight (kg), mean ± SD | 15.65 ± 5.186 | 16.12 ± 4.709 | 0.485 |
| BSA (m2), mean ± SD | 0.66 ± 0.141 | 0.69 ± 0.135 | 0.436 |
| Diagnosis, n (%) | 0.195 | ||
| Functional SV | 54 (77.1) | 178 (84.0) | |
| SV | 16 (22.9) | 34 (16.0) | |
| Modified Ross score, n (%) | 0.485 | ||
| 0 | 58 (82.9%) | 182 (86.3%) | |
| 1 | 12 (17.1%) | 29 (13.7%) | |
| > 1 | 0 (0.0%) | 0 (0.0%) | |
| Malnutrition, n (%) | 16 (22.9%) | 46 (21.7%) | 0.839 |
| Anatomic information | |||
| Combined with CAVSD, n (%) | 11 (15.7) | 24 (11.3) | 0.334 |
| Combined with TAPVC, n (%) | 1 (1.4) | 3 (1.4) | 1.000 |
| Heterotaxy, n (%) | 12 (17.1) | 18 (8.5) | 0.042* |
| Collateral circulation | 97 (45.8%) | 37 (52.8%) | 0.302 |
| Antegrade flow of Pa, n (%) | 21 (30.0) | 63 (29.7) | 0.964 |
| Common AVV, n (%) | 18 (25.7) | 33 (15.6) | 0.056 |
| Pre-AVVR, n (%) | 12 (17.1) | 28 (13.2) | 0.413 |
| Pre-SpO2 (%), median (IQR) | 80 (77–85) | 80 (80–85) | 0.422 |
| McGoon ratio median (IQR) | 2.08 (1.7 ~ 2.35) | 2.12 (1.79 ~ 2.43) | 0.210 |
| Nakata index (mm2/m2) median (IQR) | 249.69 (176.82 ~ 301.48) | 244.41 (191.20 ~ 331.30) | 0.314 |
| Hemodynamic preoperative data | |||
| mPAP (mmHg), median (IQR) | 14 (13–15) | 14 (13–16) | 0.773 |
| mABP (mmHg), median (IQR) | 68 (63–74) | 67 (61–74) | 0.258 |
| Pp/Ps, median (IQR) | 0.21 (0.18–0.24) | 0.21 (0.18–0.24) | 0.647 |
BSA Body surface area, SV Single ventricle, CAVSD Complete atrioventricular septal defect, Pa Pulmonary artery, AVV Atrioventricular valve, Pre-AVVR Preoperative atrioventricular valve regurgitation, Pre-SpO Preoperative transcutaneous oxygen saturation, mPAP mean pulmonary artery pressure, mABP mean aorta blood pressure, Pp/Ps mean pulmonary artery pressure/ mean aorta blood pressure
* P < 0.05
Comparison of operative data between prolonged and standard recovery groups
| Prolonged recovery | Standard recovery | ||
|---|---|---|---|
| CBP time (min), median (IQR) | 101 (85 ~ 145) | 69 (62 ~ 77) | 0.004* |
| Need for aortic cross-clamp, n (%) | 66 (94.3%) | 196 (92.3%) | 0.790 |
| Aortic cross-clamp time (min), median (IQR) | 62 (52 ~ 79) | 54 (45 ~ 64) | < 0.001* |
| Extracorporeal circulation mode, n (%) | 0.645 | ||
| Low flow | 1 (1.4%) | 1 (0.5%) | |
| Parallel circulation | 3 (4.3%) | 12 (5.7%) | |
| Full flow | 66 (94.3%) | 199 (93.9%) | |
| Temperature, n (%) | 0.118 | ||
| Room temperature | 8 (11.4%) | 25 (11.8%) | |
| Mild hypothermia | 38 (54.3%) | 142 (67.0%) | |
| Moderate hypothermia | 23 (32.9%) | 44 (20.8%) | |
| Deep hypothermia | 1 (1.4%) | 1 (0.5%) | |
| Fenestration, n (%) | 65 (92.9%) | 197 (92.9%) | 1.000 |
| Size of fenestration, n (%) | 0.329 | ||
| < 4 cm | 3 (4.6%) | 8 (4.1%) | |
| 4 cm | 56 (86.2%) | 180 (91.4%) | |
| > 4 cm | 6 (9.2%) | 9 (4.6%) | |
| Conduit connection, n (%) | 0.146 | ||
| Intracardiac conduits | 15 (21.4%) | 54 (25.5%) | |
| Extracardiac conduits | 53 (75.7%) | 137 (64.7%) | |
| Intra-extracardiac conduits | 2 (2.9%) | 21 (9.9%) | |
| Operation stage (I/II/III), n (%) | 0.371 | ||
| Stage I | 7 (10.0%) | 12 (5.7%) | |
| Stage II | 48 (68.6%) | 159 (75.0%) | |
| Stage III | 15 (21.4%) | 41 (19.3%) | |
| Secondary surgical procedure | 44 (62.9%) | 136 (64.2%) | 0.845 |
| Hemodynamics immediately after surgery | |||
| mPAP (mmHg), median (IQR) | 19 (16 ~ 21) | 18 (16 ~ 20) | 0.267 |
| mABP (mmHg), mean ± SD | 56.91 ± 9.824 | 57.83 ± 7.702 | 0.428 |
| Pp/Ps, median (IQR) | 0.32 (0.27 ~ 0.36) | 0.34 (0.27 ~ 0.40) | 0.082 |
CBP Cardiopulmonary bypass time, mPAP mean pulmonary artery pressure, mABP mean aorta blood pressure, Pp/Ps mean pulmonary artery pressure/ mean aorta blood pressure
* P < 0.05
Postoperative data of the two groups
| Prolonged recovery | Standard recovery | ||
|---|---|---|---|
| Mechanical ventilation time (h), median (IQR) | 44 (20–95) | 10 (8–20) | < 0.001* |
| Mechanical ventilation time, n (%) | < 0.001* | ||
| ≤ 12 h | 12 (17.1%) | 133 (62.7%) | |
| 12–24 h | 14 (20.0%) | 57 (26.9%) | |
| 24–48 h | 15 (21.4%) | 16 (7.5%) | |
| > 48 h | 29 (41.4%) | 6 (2.8%) | |
| P/F ratio after extubation, median (IQR) | 168.15 (138.64–196.79) | 202.06 (165.97–249.03) | < 0.001* |
| Hemodynamics in POD 0 | |||
| mPAP (mmHg), mean ± SD | 18.13 ± 3.101 | 16.80 ± 2.807 | 0.002* |
| mABP (mmHg), mean ± SD | 58.27 ± 9.095 | 63.45 ± 9.101 | < 0.001* |
| Pp/Ps, mean ± SD | 0.32 ± 0.077 | 0.27 ± 0.067 | < 0.001* |
| PH treatment after Fontan operation, n (%) | 63 (90.0%) | 139 (65.6%) | < 0.001* |
| Drugs in treating PH, n (%) | 0.034* | ||
| Endothelin receptor antagonists | 13 (20.6%) | 51 (37.0%) | |
| Prostacyclin analogues | 16 (25.4%) | 20 (14.5%) | |
| Combined | 34 (54.0%) | 67 (48.6%) | |
| PH treatment within two days, n (%) | 57 (81.4%) | 127 (59.9%) | 0.001* |
| Chest drainage time (day), median (IQR) | 13 (10–18) | 9 (7–14) | < 0.001* |
| Total drainage volume (ml/kg), median (IQR) | 93.12 (62.50–129.56) | 41.55 (28.48–61.82) | < 0.001* |
| Drainage volume within two days (ml/kg), median (IQR) | 67.50 (51.25–87.11) | 39.38 (27.01–57.89) | < 0.001* |
| Volume resuscitation within two days (ml/kg), n (%) | 132.14 (96.88–185.71) | 78.46 (51.72–111.00) | < 0.001* |
| Inotropic score (IS), median (IQR) | |||
| IS in POD 0 (μg/kg/min) | 20.5 (13.5–35) | 15 (10.5–18.5) | < 0.001* |
| IS in POD 1 (μg/kg/min) | 20 (13–30) | 11 (7.5–14.3) | < 0.001* |
| IS in POD 2 (μg/kg/min) | 17 (10–29.6) | 8 (6–12.5) | < 0.001* |
| Surgical reintervention, n (%) | 16 (22.9%) | 11 (5.2%) | < 0.001* |
| Hospital stay (day), median (IQR) | 21 (15–28) | 15 (12–19) | < 0.001* |
| Hospitalization costs (dollar), mean ± SD | 18,093.81 ± 6953.094 | 12,535.55 ± 10,039.343 | < 0.001* |
| Readmission within two months after discharge, n (%) | 13 (18.6%) | 18 (8.5%) | 0.019* |
| Complications | |||
| Hypoxemia, n (%) | 49 (70%) | 66 (31.1%) | < 0.001* |
| cardiac output syndrome, n (%) | 44 (62.9%) | 53 (25.0%) | < 0.001* |
| Liver disfunction, n (%) | 26 (37.1%) | 34 (16.0%) | < 0.001* |
| Arrhythmia n (%) | 24 (34.3%) | 60 (28.3%) | 0.343 |
| disfunction, n (%) | 20 (28.6%) | 17 (8.0%) | < 0.001* |
| Atrioventricular valve regurgitation, n (%) | 13 (18.6%) | 21 (9.9%) | 0.054 |
POD 0 was defined as the time from the patient transfer to CICU to 7 a.m. the next day. POD 1 was the time from 8 a.m. on day 1 of surgery to 7 a.m. the next day. POD 2 was the time from 8 a.m. on the second day of surgery to 7 a.m. on day 3
P/F ratio oxygen index, mPAP mean pulmonary artery pressure, mABP mean aorta blood pressure, Pp/Ps mean pulmonary artery pressure/mean aorta blood pressure, PH Pulmonary hypertension
* P < 0.05
Prediction factors for prolonged recovery after Fontan operation
| Model 1 | Model 2 | |||||
|---|---|---|---|---|---|---|
| Univariable analysis | Multivariable analysis | Multivariable analysis | ||||
| OR (95%CI) | OR (95%CI) | OR (95%CI) | ||||
| Mechanical ventilation time (h)a | 0.000 | 1.056 (1.039–1.073) | 0.000 | 1.051 (1.032–1.071) | ||
| Heterotaxy | 0.046 | 2.230 (1.015 ~ 4.899) | ||||
| Cardiopulmonary bypass time (min) | < 0.001 | 1.012 (1.005 ~ 1.018) | ||||
| Aortic cross-clamp time (min) | 0.002 | 1.018 (1.006 ~ 1.029) | ||||
| Postoperative reintervention, n (%) | < 0.001 | 5.414 (2.374 ~ 12.346) | ||||
| P/F ratio after extubation | 0.023 | 0.995 (0.991 ~ 0.999) | ||||
| mPAP in POD 0 (mmHg) | 0.002 | 1.177 (1.060 ~ 1.306) | ||||
| mABP in POD 0 (mmHg) | < 0.001 | 0.939 (0.908 ~ 0.971) | ||||
| Pp/Ps in POD 0 | < 0.001 | 9048.856 (135.136 ~ 605,921.471) | ||||
| IS in POD 0 (μg/kg/min) | < 0.001 | 1.050 (1.025 ~ 1.076) | 0.042 | 1.031 (1.001 ~ 1.061) | ||
| PH treatment within two days | 0.001 | 2.935 (1.514 ~ 5.690) | 0.038 | 2.627 (1.053 ~ 6.553) | ||
| Drainage volume within two days (ml/kg) | < 0.001 | 1.029 (1.018 ~ 1.040) | ||||
| Fluid resuscitation within two days (ml/kg) | < 0.001 | 1.017 (1.011 ~ 1.023) | 0.000 | 1.015 (1.009 ~ 1.021) | 0.000 | 1.012 (1.006–1.019) |
P/F ratio oxygen index, mPAP mean pulmonary artery pressure, mABP mean aorta blood pressure, Pp/Ps mean pulmonary artery pressure/ mean aorta blood pressure, IS Inotropic score, PH Pulmonary hypertension
a The factor was not included in the Model 1
Fig. 1Ability in predicting prolonged Fontan recovery using the three combined factors (IS in POD 0, PH treatment, and fluid resuscitation within two days).